In spite of many years of research, the question of whether patients with hepatic encephalopathy (HE) have disturbed brain energy metabolism and hemodynamics remains unsolved. Ammonia has been proposed to play an important role in the pathogenesis of the development of HE,¹ x 1 Sherlock, S., Summerskill, W.H., White, L.P. et al. Portal-systemic encephalopathy; neurological complications of liver disease. Lancet. 1954; 267: 453–457 Abstract | Scopus (203) | Google Scholar See all References ^{, 2} x 2 Lockwood, A.H., McDonald, J.M., Reiman, R.E. et al. The dynamics of ammonia metabolism in man: effects of liver disease and hyperammonemia. J Clin Invest. 1979; 63: 449–460 Crossref | PubMed | Scopus (258) | Google Scholar See all References ^{, 3} x 3 Cooper, A.J. and Plum, F. Biochemistry and physiology of brain ammonia. Physiol Rev. 1987; 67: 440–519 PubMed | Google Scholar See all References ^{, 4} x 4 Butterworth, R.F., Giguere, J.-F., Michaud, J. et al. Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochem Pathol. 1987; 6: 1–12 Crossref | PubMed | Scopus (304) | Google Scholar See all References ^{, 5} x 5 Jones, E.A. and Basile, A.S. Does ammonia contribute to increased GABA-ergic neurotransmission in liver failure?. Metab Brain Dis. 1998; 13: 351–360 Crossref | PubMed | Scopus (34) | Google Scholar See all References ^{, 6} x 6 Butterworth, R.F. Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab Brain Dis. 2002; 17: 221–227 Crossref | PubMed | Scopus (231) | Google Scholar See all References ^{, 7} x 7 Ott, P. and Larsen, F.S. Blood-brain barrier permeability to ammonia in liver failure: a critical reappraisal. Neurochem Int. 2004; 44: 185–198 Crossref | PubMed | Scopus (79) | Google Scholar See all References ^{, 8} x 8 Ott, P., Clemmesen, O., and Larsen, F.S. Cerebral metabolic disturbances in the brain during acute liver failure: from hyperammonemia to energy failure and proteolysis. Neurochem Int. 2005; 47: 13–18 Crossref | PubMed | Scopus (74) | Google Scholar See all References primarily because of consistent findings of elevated blood ammonia in patients with HE, and because ammonia inhibits key enzymes in the oxidative energy metabolism in vitro.⁹ x 9 Lai, J.C. and Cooper, A.J. Brain α-ketoglutarate dehydrogenase complex: kinetic properties, regional distribution, and effects of inhibitors. J Neurochem. 1986; 47: 1376–1386 Crossref | PubMed | Scopus (232) | Google Scholar See all References ^{, 10} x 10 Zwingmann, C., Chatauret, N., Leibfritz, D. et al. Selective increase of brain lactate synthesis in experimental acute liver failure: results of a [H-C] nuclear magnetic resonance study. Hepatology. 2003; 37: 420–428 Crossref | PubMed | Scopus (141) | Google Scholar See all References Brain uptake of ammonia is proportional to the arterial blood concentration of ammonia,² x 2 Lockwood, A.H., McDonald, J.M., Reiman, R.E. et al. The dynamics of ammonia metabolism in man: effects of liver disease and hyperammonemia. J Clin Invest. 1979; 63: 449–460 Crossref | PubMed | Scopus (258) | Google Scholar See all References ^{, 11} x 11 Keiding, S., Sørensen, M., Bender, D. et al. Brain metabolism of ¹³N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography. Hepatology. 2006; 43: 42–50 (Correction in Hepatology 2006;44:1056) Crossref | PubMed | Scopus (85) | Google Scholar See all References which could link the elevated blood concentration of ammonia in patients with HE to disturbances in cerebral energy metabolism.⁸ x 8 Ott, P., Clemmesen, O., and Larsen, F.S. Cerebral metabolic disturbances in the brain during acute liver failure: from hyperammonemia to energy failure and proteolysis. Neurochem Int. 2005; 47: 13–18 Crossref | PubMed | Scopus (74) | Google Scholar See all References ^{, 9} x 9 Lai, J.C. and Cooper, A.J. Brain α-ketoglutarate dehydrogenase complex: kinetic properties, regional distribution, and effects of inhibitors. J Neurochem. 1986; 47: 1376–1386 Crossref | PubMed | Scopus (232) | Google Scholar See all References ^{, 10} x 10 Zwingmann, C., Chatauret, N., Leibfritz, D. et al. Selective increase of brain lactate synthesis in experimental acute liver failure: results of a [H-C] nuclear magnetic resonance study. Hepatology. 2003; 37: 420–428 Crossref | PubMed | Scopus (141) | Google Scholar See all References ^{, 12} x 12 Johansen, M.L., Bak, L.K., Schousboe, A. et al. The metabolic role of isoleucine in detoxification of ammonia in cultured mouse neurons and astrocytes. Neurochem Int. 2007; 50: 1042–1051 Crossref | PubMed | Scopus (36) | Google Scholar See all References Early studies found reduced cerebral oxygen consumption¹³ x 13 Fazekas, J.F., Ticktin, H.E., Wilfred, R. et al. Cerebral metabolism in hepatic insufficiency. Am J Med. 1956; 21: 843–849 Abstract | Full Text PDF | PubMed | Scopus (63) | Google Scholar See all References ^{, 14} x 14 Posner, J.B. The toxic effects of carbon dioxide and acetazolamide in hepatic encephalopathy. J Clin Invest. 1960; 39: 1246–1258 Crossref | PubMed | Scopus (105) | Google Scholar See all References ^{, 15} x 15 Morgan, M.Y., Jakobovits, A.W., James, I.M. et al. Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology. 1980; 78: 663–670 PubMed | Google Scholar See all References ^{, 16} x 16 Philips, B.J., Armstrong, I.R., Pollock, A. et al. Cerebral blood flow and metabolism in patients with chronic liver disease undergoing orthotopic liver transplantation. Hepatology. 1998; 27: 369–376 Crossref | PubMed | Scopus (35) | Google Scholar See all References ^{, 17} x 17 Strauss, G.I., Møller, K., Larsen, F.S. et al. Cerebral glucose and oxygen metabolism in patients with fulminant hepatic failure. Liver Transpl. 2003; 9: 1244–1252 Crossref | PubMed | Scopus (25) | Google Scholar See all References and blood flow¹³ x 13 Fazekas, J.F., Ticktin, H.E., Wilfred, R. et al. Cerebral metabolism in hepatic insufficiency. Am J Med. 1956; 21: 843–849 Abstract | Full Text PDF | PubMed | Scopus (63) | Google Scholar See all References ^{, 14} x 14 Posner, J.B. The toxic effects of carbon dioxide and acetazolamide in hepatic encephalopathy. J Clin Invest. 1960; 39: 1246–1258 Crossref | PubMed | Scopus (105) | Google Scholar See all References ^{, 15} x 15 Morgan, M.Y., Jakobovits, A.W., James, I.M. et al. Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology. 1980; 78: 663–670 PubMed | Google Scholar See all References ^{, 16} x 16 Philips, B.J., Armstrong, I.R., Pollock, A. et al. Cerebral blood flow and metabolism in patients with chronic liver disease undergoing orthotopic liver transplantation. Hepatology. 1998; 27: 369–376 Crossref | PubMed | Scopus (35) | Google Scholar See all References ^{, 17} x 17 Strauss, G.I., Møller, K., Larsen, F.S. et al. Cerebral glucose and oxygen metabolism in patients with fulminant hepatic failure. Liver Transpl. 2003; 9: 1244–1252 Crossref | PubMed | Scopus (25) | Google Scholar See all References ^{, 18} x 18 Almdal, T., Schroeder, T., and Ranek, L. Cerebral blood flow and liver function in patients with encephalopathy due to acute and chronic liver diseases. Scand J Gastroenterol. 1989; 24: 299–303 Crossref | PubMed | Scopus (65) | Google Scholar See all References in cirrhotic patients with chronic or nonspecified HE based on measurements of arterial-venous blood differences of oxygen concentration, with venous blood samples from the jugular bulb (the Kety–Schmidt method¹⁹ x 19 Kety, S.S. and Schmidt, C.F. The nitrous oxide method for the quantitative determination of cerebral blood flow in man: theory, procedure and normal values. J Clin Invest. 1948; 27: 476–483 Crossref | PubMed | Scopus (955) | Google Scholar See all References ). However, such measurements are inevitably contaminated by extracerebral venous blood, possibly introducing biases of the results.

In patients with impaired liver function and hepatic encephalopathy (HE), consistent elevations of blood ammonia concentration suggest a crucial role in the pathogenesis of HE. Ammonia and acetate are metabolized in brain both primarily in astrocytes. Here, we used dynamic [¹¹C]acetate PET of the brain to measure the contribution of astrocytes to the previously observed reduction of brain oxidative metabolism in patients with liver cirrhosis and HE, compared to patients with cirrhosis without HE, and to healthy subjects. We used a new kinetic model to estimate uptake from blood to astrocytes and astrocyte metabolism of [¹¹C]acetate. No significant differences of the rate constant of oxidation of [¹¹C]acetate (k₃) were found among the three groups of subjects. The net metabolic clearance of [¹¹C]acetate from blood was lower in the group of patients with cirrhosis and HE than in the group of healthy subjects (P < 0.05), which we interpret to be an effect of reduced cerebral blood flow rather than a reflection of low [¹¹C]acetate metabolism. We conclude that the characteristic decline of whole-brain oxidative metabolism in patients with cirrhosis with HE is not due to malfunction of oxidative metabolism in astrocytes. Thus, the observed decline of brain oxidative metabolism implicates changes of neurons and their energy turnover in patients with HE.